Article
p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade
29 Dec 2021
Abstract excerpt
Squamous cell carcinoma driven by human papillomavirus (HPV) is more sensitive to DNA-damaging therapies than its HPV-negative counterpart. Here, we show that p16, the clinically used surrogate for HPV positivity, renders cells more sensitive to radiotherapy via a ubiquitin-dependent signaling pathway, linking high levels of this protein to increased activity of the transcription factor SP1, increased HUWE1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
